Rare diseases
Investigational molecules
Locations
Study on the Safety and Effects of AZD5305 with Hormonal Agents for Patients with Metastatic Prostate Cancer
ItalyStudy on Trastuzumab Emtansine, Pertuzumab, and Atezolizumab for Patients with HER2-Positive Metastatic Cancer Who Benefited from Previous Treatment
BelgiumStudy of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy
BelgiumStudy on Tisagenlecleucel for High-Risk B-Cell Acute Lymphoblastic Leukemia in Pediatric and Young Adult Patients with Minimal Residual Disease
BelgiumStudy of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy
BelgiumStudy Comparing Nivolumab and Ipilimumab with Chemotherapy to Chemotherapy Alone for Patients with Stage IV Non-Small Cell Lung Cancer
BelgiumStudy of Tocilizumab Treatment for Chronic Antibody-Mediated Rejection in Kidney Transplant Recipients
SpainStudy on the Effects and Safety of Crovalimab for Adults and Adolescents with Atypical Hemolytic Uremic Syndrome (aHUS)
BelgiumStudy of Tobemstomig with Platinum-Based Chemotherapy vs Pembrolizumab with Platinum-Based Chemotherapy for Untreated Non-Small Cell Lung Cancer Patients
BelgiumStudy of Apalutamide and Androgen Deprivation Therapy for Patients with Metastatic Hormone-sensitive Prostate Cancer
CzechiaStudy on the Effectiveness of Apalutamide in Men with Castration-Resistant Prostate Cancer
AustriaStudy on the Safety and Effectiveness of LASN01 for Patients with Thyroid Eye Disease
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
